GSK’s (GSK) Equal Weight Rating Reaffirmed at Barclays
The Cerbat Gem - 2024-04-12T01:24:41.000Z

Barclays reiterated their equal weight rating on shares of GSK (LON:GSK – Free Report) in a report released on Monday, MarketBeat Ratings reports. Barclays currently has a GBX 1,725 ($21.83) price target on the stock. Several other equities research analysts also recently weighed in on GSK. Berenberg Bank raised their price target on GSK from […] Read this story